A decades-old medicine has unexpectedly opened a new door in kidney research. Scientists at Mayo Clinic have discovered a previously unknown way the kidneys control water balance, a finding that could change how certain kidney diseases are treated. The discovery came from studying a drug first developed in the 1940s, revealing a hidden process that may help patients with polycystic kidney disease and other conditions, as per Medical Xpress.The study, led by Fouad Chebib, M.D., a nephrologist at Mayo Clinic, was published in the Journal of Clinical Investigation. Researchers say the findings could eventually contribute to improved treatments for polycystic kidney disease (PKD) and other kidney disorders.“The kidney's ability to regulate water is one of the most fundamental processes in the body,” Chebib says. “It's not every day that you uncover a new way it carries out that function.”You Might Also Like:How Was The Hidden Kidney Pathway Found?For years, scientists believed the kidney’s ability to conserve water mainly depended on the hormone vasopressin. This hormone helps the body prevent dehydration by controlling how much water is reabsorbed by the kidneys.However, Chebib’s team discovered that the kidneys have another mechanism that works independently of vasopressin.The discovery came while researchers were studying polycystic kidney disease, an inherited condition where fluid-filled cysts grow inside the kidneys over time. These cysts can gradually damage kidney function and may eventually lead to kidney failure.PKD affects millions of people worldwide, including an estimated 140,000 people in the United States with the most common form, autosomal dominant PKD (ADPKD).You Might Also Like:During laboratory studies using kidney cell models, researchers tested different compounds that they expected would increase signals connected to cyst growth. One of the drugs examined was probenecid, a medication first introduced in the 1940s to help preserve limited supplies of penicillin by reducing how quickly the body removed it through urine.However, the results surprised the team. “We thought this drug would make the disease process worse,” Chebib says. “Instead, it did the opposite.”Rather than increasing cyst growth, probenecid actually slowed the process, as per Medical Xpress.Why Could This Matter For PKD Patients?Further research showed that probenecid influences how kidney cells manage urate, a molecule commonly linked with gout.Inside kidney cells, urate works as a signal that activates a series of events. This process helps move water channels to the cell surface, allowing the kidneys to absorb water and create concentrated urine without relying only on vasopressin.“This represents a distinct pathway from what is described in traditional physiology models,” Chebib says. “It demonstrates that the kidney has an additional mechanism to preserve water.”The discovery could be especially important for people with PKD because current treatments come with challenges.The only approved therapy, tolvaptan, works by blocking vasopressin. While it can slow cyst growth, it often causes patients to produce very large amounts of urine — sometimes 6 to 7 liters per day. The side effects can become difficult for patients and may lead some to stop treatment, as per Medical Xpress.Researchers found that adding probenecid in preclinical studies and a small clinical trial helped reduce urine volume while keeping the treatment benefits.After taking probenecid, patients experienced about a 30% reduction in urine volume on average. They also reported fewer nighttime trips to the bathroom, improving daily quality of life.“The goal is to preserve the therapeutic benefit of tolvaptan while reducing its burden,” Chebib says.What Happens Next In Research?Although probenecid helped reveal this important pathway, researchers do not see it as the final treatment solution. The drug is decades old, affects multiple systems in the body, and is not widely used today. Instead, the team hopes to use this discovery to create more targeted therapies designed specifically around the newly identified mechanism.“Probenecid helped us uncover the mechanism,” Chebib says. “Our goal is to take this insight and develop therapies designed specifically for this pathway.”For Chebib, the research also carries personal meaning. His interest in kidney disease research began after his father developed PKD, as per Medical Xpress.“This has been a long and deeply purposeful journey,” he says. “It started with a personal motivation and led to something that could ultimately benefit patients.”The findings offer a new understanding of how the kidneys maintain water balance and may provide a future direction for treating kidney diseases that affect millions of people.FAQsWhat did researchers discover?A new kidney water-control pathway.What drug helped reveal it?The 1940s drug was probenecid.